|
Biochemical Journal and Clinical Science buck Impact Factor trend
In the 2008 JCR released by Thomson Reuters on Friday 19 June, both the Biochemical Journal and Clinical Science saw their Impact Factors rise.
The Impact Factor for the Biochemical Journal rose to 4.371, while other broad-based journals such as Journal of Molecular Biology, Biochemistry, Molecular and Cellular Biology, Molecular Biology of the Cell, Journal of Biological Chemistry and the FEBS Journal saw their Impact Factors fall or stand still. The Immediacy Index (a measure of how soon papers are cited) for the Biochemical Journal increased, for the second year running, to 1.29, comparable with the Immediacy Index values of a number of other journals in the cellular and molecular biology area with Impact Factors above 5. Professor Peter Shepherd, Chair of the Editorial Board, said “ These new metrics are a reflection of the increase in quality of the papers published in the BJ and the way in which the journal's content is presented online in Knowledge Environments - this has increased the visibility of papers to both specific communities and to a wider audience, to the benefit of authors publishing in the journal.”
Clinical Science has seen its Impact Factor almost double in the last 6 years and has a new Impact Factor of 4.187. “This latest increase in Impact Factor has taken the journal up to a ranking of 13/82 in the ISI Medicine (Research and Experimental) category, putting it above a number of other journals in the translational science area, such as the Journal of Translational Medicine and the European Journal of Clinical Investigation” said Professor Clinton R Webb, Editor-in-Chief. “This is an extremely important stage in the journal’s development and as an Editorial Board we will be building on this success in the future.”
|
|
|
|
| |
|
|
|
More top news stories
|
|
search our archive
